XML 32 R44.htm IDEA: XBRL DOCUMENT v3.20.1
Note 9 - BioLargo Engineering, Science and Technologies, LLC (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 25 Months Ended
Sep. 30, 2017
Mar. 31, 2020
Mar. 31, 2019
Sep. 30, 2019
Nov. 04, 2019
Share-based Payment Arrangement, Noncash Expense, Total   $ 526 $ 352    
Percentage of Profits Interests Vested         2.50%
Seven Employees Working at BioLargo Engineering, Science & Technologies, LLC [Member]          
Deferred Compensation Arrangement with Individual, Requisite Service Period (Year) 5 years        
Potential Ownership Percentage of Subsidiary Held by Subsidiary Employees Based on Performance 30.00%        
Incentive Issuance Stipulations for Subsidiary Employees, Accounts Receivable Collected by Year One of Operation 90.00%        
Incentive Issuance Stipulations for Subsidiary Employees, Profit Earned in Year One of Operation 10.00%        
Seven Employees Working at BioLargo Engineering, Science & Technologies, LLC [Member] | Non-Qualified Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) 1,750,000        
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) 5 years        
Share-based Payment Arrangement, Noncash Expense, Total       $ 0  
BioLargo Engineering, Science & Technologies, LLC [Member]          
Noncontrolling Interest, Ownership Percentage by Parent 100.00% 97.50%